Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.
Press releases published on April 25, 2025

Hartcoin Launches Most Profitable AI-Powered Cloud Mining Platform of 2025 Amid Market Uncertainty
LONDON, UK , April 25, 2025 (GLOBE NEWSWIRE) -- Amid ongoing volatility in global markets and the cryptocurrency sector, Hartcoin, an AI-powered cloud mining platform, is drawing worldwide attention by providing one of the most profitable and accessible …

MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29 Zug, Switzerland, April 25, 2025 – MoonLake Immunotherapeutics (Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory …

Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting
SALT LAKE CITY, April 25, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced new clinical data will be shared at the American Association for Cancer Research (AACR) …

Prelude Announces Presentations at 2025 AACR Annual Meeting
Preclinical data elucidating the mechanism of action of PRT3789, Prelude’s first-in-class, highly selective SMARCA2 degrader currently in early clinical development Highlights from Prelude’s efforts to discover and develop selective KAT6A degraders, …

Epsilon Energy Ltd. Schedules First Quarter 2025 Earnings Release and Conference Call
HOUSTON, April 25, 2025 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today announced that it will issue its first quarter 2025 earnings release on Wednesday, May 14, 2025 after the market close and host a conference …

AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance
IRVINE, Calif., April 25, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications …

Prehost.com Releases Technical Analysis on Web Hosting's Impact on SEO Performance
Experts reveal why your choice of hosting provider can make—or break—your search‐ranking and user experience CA, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- In today’s ultra-competitive digital landscape, businesses often focus on content, …

EPC-RPU: AI-Powered Embedded System for Automation, Retail, and Healthcare
TAIPEI, TAIWAN, April 25, 2025 /EINPresswire.com/ -- Avalue Technology Inc. (TAIEX: 3479-TW), a global leader in industrial computing solutions, has officially announced its latest high-performance embedded system EPC-RPU, featuring the Intel® 13th …

Spanios and White Lion Capital LLC Announce Strategic Partnership to Accelerate Drug Development
HOUSTON, April 25, 2025 (GLOBE NEWSWIRE) -- Spanios, a leader in human-derived organoid model systems, is pleased to announce a strategic partnership with White Lion Capital LLC. This collaboration empowers biotech and pharma companies to leverage Spanios’ …

Pangu Launches Otherworlds.ai, a Fully On-Chain Web3 Strategy Game Powered by AI
Singapore, April 25, 2025 (GLOBE NEWSWIRE) -- Developer Pangu has released Otherworlds.ai, a lightweight, AI-powered strategy game that is optimized for instant browser play and offers complete on-chain transparency. This follows the success of MetaCene, …

Tevogen Bio Announces 2025 Annual Meeting
WARREN, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen Bio” or “Company”) (Nasdaq: TVGN) today announced that the Company will hold its 2025 annual meeting of stockholders (the “Annual Meeting”) via live webcast at 11 a.m. …

N2 Infotech commercializes AI-based elevator predictive maintenance solution: Expanding market on public institutions
N2 Infotech rolls out an AI-based elevator maintenance system that targets public institutions with smart, usage-based predictive tech for global expansion. PANGYO, GYEONGGI-DO, SOUTH KOREA, April 25, 2025 /EINPresswire.com/ -- A predictive maintenance …

Colle AI Increases Platform Speed With Targeted Core Upgrades
Backend improvements reduce latency, improve AI response time, and accelerate NFT processing across chains LONDON , LONDON, UNITED KINGDOM, April 25, 2025 /EINPresswire.com/ -- Colle AI (COLLE), the multichain AI-NFT platform, has completed a series of …

Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC
Gene signatures associated with increased efficacy of micvotabart pelidotin (MICVO) due to greater linker cleavage were identified based on differential gene expression analysis of PDX responders/non-responders Mouse analog of MICVO in a syngeneic model …

AGII Refines Blockchain Speed With Real-Time Smart Contract Logic
Enhancing Web3 Through Instantaneous Execution and Scalable Contract Automation SEATTLE, WA, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- AGII, the intelligent Web3 platform powered by advanced AI, announced a breakthrough refinement in smart …

Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Annual Meeting 2025
PARAMUS, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal technologies, announced today the presentation of positive data …

ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma
- Data to be presented at AACR 2025 Annual Meeting suggest the combination of ALX Oncology’s investigational CD47-blocker, evorpacept, plus rituximab and lenalidomide (R2) was well-tolerated and demonstrated promising anti-tumor activity - Combination …

IMA360 Achieves 112% Revenue Growth and Expands Partnerships with McKesson and BRP
IRVING, TX, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- IMA360, a Texas-based provider of cloud-native profit optimization solutions, is pleased to announce it has recorded a 112% revenue growth in its 2024 fiscal year, in addition to acquiring …

T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
– TK-6302, a supercharged PRAME targeting TCR-T therapy, demonstrates best-in-class preclinical anti-tumor efficacy as compared to current clinical stage PRAME TCR-T approaches, providing the potential for broad, deep and durable responses in hard-to-treat …

Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025
Novel analytical framework establishes a clinically meaningful performance assessment of blood-based early detection tests Innovative methodology enhances cancer signal detection, boosts specificity and predictive value Presentations further validate the …